Cabaletta Bio News - CABA

Company Name	Stock Ticker Symbol	Market	Type
Cabaletta Bio Inc	CABA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-1.18	-7.79%	13.97	17:40:17

Open Price	Low Price	High Price	Close Price	Prev Close
15.00	13.79	15.00	13.97	15.15

more quote information »

Recent News

Date	Time	Source	Heading
3/21/2024	07:00	GLOBE	Cabaletta Bio Reports Fourth Quarter and Full Year 2023..
3/20/2024	07:00	GLOBE	Cabaletta Bio Announces FDA Granted Orphan Drug Designation..
3/04/2024	17:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/27/2024	08:00	GLOBE	Cabaletta Bio to Participate in Upcoming Investor..
2/14/2024	09:20	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	18:47	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/01/2024	16:36	EDGAR2	Form 8-K - Current report
2/01/2024	16:30	GLOBE	Cabaletta Bio Announces FDA Granted Orphan Drug Designation..
1/31/2024	08:00	GLOBE	Cabaletta Bio to Participate in the Guggenheim Healthcare..
1/19/2024	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	07:11	EDGAR2	Form 8-K - Current report
1/08/2024	07:00	GLOBE	Cabaletta Bio Receives Additional FDA Fast Track..
1/02/2024	08:00	GLOBE	Cabaletta Bio to Present at the 42nd Annual J.P. Morgan..
12/19/2023	20:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/29/2023	06:18	IHMARKETNEWS	Amazon Unveils Innovative Services, Okta Discloses Data..
11/28/2023	16:30	GLOBE	Cabaletta Bio to Participate in the 6th Annual Evercore ISI..
11/28/2023	14:59	DJN	Cabaletta Bio Down as FDA Looks Into Issues With Several..
11/21/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/20/2023	16:16	EDGAR2	Form 144 - Report of proposed sale of securities
11/09/2023	07:24	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	07:12	EDGAR2	Form 8-K - Current report
11/09/2023	07:00	GLOBE	Cabaletta Bio Reports Third Quarter 2023 Financial Results..
11/06/2023	08:15	BW	Cellares and Cabaletta Bio Partner to Evaluate Automated..
11/06/2023	07:55	DJN	Cabaletta Bio Gets FDA OK to Study CABA-201 in Generalized..
11/06/2023	07:03	EDGAR2	Form 8-K - Current report
11/06/2023	07:00	GLOBE	Cabaletta Bio Receives FDA Clearance of CABA-201 IND..
10/30/2023	08:00	GLOBE	Cabaletta Bio to Participate in Multiple Upcoming Investor..
10/19/2023	19:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	16:03	EDGAR2	Form 144 - Report of proposed sale of securities
10/02/2023	07:38	EDGAR2	Form 8-K - Current report
10/02/2023	07:00	GLOBE	Cabaletta Bio Receives FDA Clearance of IND Application for..
9/20/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/19/2023	16:23	EDGAR2	Form 144 - Report of proposed sale of securities
9/19/2023	08:00	GLOBE	Cabaletta Bio to Participate in Upcoming Investor..
9/05/2023	08:45	EDGAR2	Form 8-K - Current report
8/30/2023	08:00	GLOBE	Cabaletta Bio to Participate in Multiple Upcoming Investor..
8/22/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/22/2023	08:03	EDGAR2	Form 8-K - Current report
8/22/2023	08:00	GLOBE	Cabaletta Bio and WuXi Advanced Therapies Announce Expansion..
8/21/2023	16:19	EDGAR2	Form 144 - Report of proposed sale of securities
8/10/2023	07:57	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/10/2023	07:50	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	07:16	EDGAR2	Form 8-K - Current report
8/10/2023	07:00	GLOBE	Cabaletta Bio Reports Second Quarter 2023 Financial Results..
7/24/2023	08:06	EDGAR2	Form 8-K - Current report
7/24/2023	08:00	GLOBE	Cabaletta Bio Appoints Global Commercial Leader Shawn..